Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Kezar Life Sciences, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q3 2025
- Shares held
- 4.46M
- +303.7K (+7.3%) vs. Q3 2025
- Total value
- $28.1M
- +$11.8M (+73.1%) vs. Q3 2025
- New holders
- 11
- 10 more added
- Sold out
- 6
- 17 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 720,787 | $4.53M | 4.01% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 716,759 | $4.51M | 0.11% | 00.0% | Unchanged |
| Tang Capital Management LLC | 664,314 | $4.18M | 0.21% | −55,686−7.7% | Reduced |
| Vanguard Group Inc | 341,404 | $2.15M | 0.00% | +73,238+27.3% | Added |
| Nantahala Capital Management, LLC | 276,754 | $1.74M | 0.10% | +276,754 | New |
| Affinity Asset Advisors, LLC | 229,076 | $1.44M | 0.10% | +229,076 | New |
| Stonepine Capital Management, LLC | 156,179 | $982.4K | 0.78% | −227,003−59.2% | Reduced |
| Renaissance Technologies LLC | 131,285 | $825.8K | 0.00% | +15,400+13.3% | Added |
| Peapod Lane Capital LLC | 126,699 | $796.9K | 0.68% | +926+0.7% | Added |
| Acadian Asset Management LLC | 125,371 | $787.0K | 0.00% | −8,154−6.1% | Reduced |
| ADAR1 Capital Management, LLC | 117,440 | $738.7K | 0.06% | −7,527−6.0% | Reduced |
| Ikarian Capital, LLC | 102,211 | $642.9K | 0.08% | −4,690−4.4% | Reduced |
| BlackRock, Inc. | 98,684 | $620.7K | 0.00% | +581+0.6% | Added |
| Rangeley Capital, LLC | 85,926 | $540.5K | 0.47% | +85,926 | New |
| Aldebaran Capital, LLC | 80,630 | $507.2K | 0.45% | +80,630 | New |
| Geode Capital Management, LLC | 68,167 | $428.9K | 0.00% | +2,665+4.1% | Added |
| Prelude Capital Management, LLC | 52,929 | $332.9K | 0.02% | +52,929 | New |
| Bridgeway Capital Management, LLC | 51,638 | $324.8K | 0.01% | +10,638+25.9% | Added |
| FNY Investment Advisers, LLC | 50,000 | $314.0K | 0.09% | +50,000 | New |
| Vazirani Asset Management LLC | 48,428 | $304.6K | 1.85% | +48,428 | New |
| Shay Capital LLC | 33,699 | $212.0K | 0.03% | −33,962−50.2% | Reduced |
| RBF Capital, LLC | 28,144 | $177.0K | 0.01% | −109−0.4% | Reduced |
| State Street Corp | 27,093 | $170.4K | 0.00% | +6,000+28.4% | Added |
| Dimensional Fund Advisors LP | 26,543 | $167.0K | 0.00% | +3,312+14.3% | Added |
| Nano Cap New Millennium Growth Fund L P | 25,000 | $157.3K | 0.13% | +25,000 | New |
| Torno Capital, LLC | 20,000 | $125.8K | 0.05% | +20,000 | New |
| Boothbay Fund Management, LLC | 16,210 | $102.0K | 0.00% | −4,690−22.4% | Reduced |
| Northern Trust Corp | 13,763 | $86.6K | 0.00% | −177−1.3% | Reduced |
| Two Sigma Investments, LP | 11,312 | $71.2K | 0.00% | −12,370−52.2% | Reduced |
| Wells Fargo & Company | 5,836 | $36.7K | 0.00% | −10−0.2% | Reduced |
| Morgan Stanley | 5,685 | $35.8K | 0.00% | −2,135−27.3% | Reduced |
| Global Retirement Partners, LLC | 1,000 | $6.29K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 564 | $3.55K | 0.00% | −623−52.5% | Reduced |
| FMR LLC | 208 | $1.31K | 0.00% | −8,524−97.6% | Reduced |
| Royal Bank of Canada | 112 | $1.00K | 0.00% | +112 | New |
| Bank of America Corp | 122 | $768 | 0.00% | +1+0.8% | Added |
| JPMorgan Chase & Co | 109 | $686 | 0.00% | −100−47.8% | Reduced |
| CIBC Private Wealth Group, LLC | 100 | $629 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 94 | $591 | 0.00% | +4+4.4% | Added |
| BNP Paribas Arbitrage, SA | 89 | $560 | 0.00% | −7−7.3% | Reduced |
| Allworth Financial LP | 50 | $315 | 0.00% | +50 | New |
| UBS Group AG | 40 | $252 | 0.00% | −316−88.8% | Reduced |
| Barclays PLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −192,700−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −54,261−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −33,610−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −18,221−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −13,042−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Qiming U.S. Ventures Management, LLC | – | – | – | – | Not filed |